Clinical Trials
2 trialsNCT05098990 2021-10-29
Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed